{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Gao C"],"funding":["Major New Drugs Innovation and Development"],"pagination":["71"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7222444"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["18(1)"],"pubmed_abstract":["<h4>Background</h4>Although many therapeutic strategies for Alzheimer's disease (AD) have been explored, these strategies are seldom used in the clinic. Therefore, AD therapeutic research is still urgently needed. One major challenge in the field of nanotherapeutics is to increase the selective delivery of drugs to a targeted location. Herein, we devised and tested a strategy for delivery of nanoparticles to neurons to inhibit tau aggregation by directly targeting p-tau.<h4>Results</h4>Curcumin (CUR) is loaded onto red blood cell (RBC) membrane-coated PLGA particles bearing T807 molecules attached to the RBC membrane surface (T807/RPCNP). With the advantage of the suitable physicochemical properties of the PLGA nanoparticles and the unique biological functions of the RBC membrane, the RPCN"],"journal":["Journal of nanobiotechnology"],"pubmed_title":["Neuron tau-targeting biomimetic nanoparticles for curcumin delivery to delay progression of Alzheimer's disease."],"pmcid":["PMC7222444"],"funding_grant_id":["2018ZX09711003-008-001"],"pubmed_authors":["Zheng J","Li Z","Yang Y","Xie X","Yang M","Chu X","Wang Y","Gao C","Gong W"],"additional_accession":[]},"is_claimable":false,"name":"Neuron tau-targeting biomimetic nanoparticles for curcumin delivery to delay progression of Alzheimer's disease.","description":"<h4>Background</h4>Although many therapeutic strategies for Alzheimer's disease (AD) have been explored, these strategies are seldom used in the clinic. Therefore, AD therapeutic research is still urgently needed. One major challenge in the field of nanotherapeutics is to increase the selective delivery of drugs to a targeted location. Herein, we devised and tested a strategy for delivery of nanoparticles to neurons to inhibit tau aggregation by directly targeting p-tau.<h4>Results</h4>Curcumin (CUR) is loaded onto red blood cell (RBC) membrane-coated PLGA particles bearing T807 molecules attached to the RBC membrane surface (T807/RPCNP). With the advantage of the suitable physicochemical properties of the PLGA nanoparticles and the unique biological functions of the RBC membrane, the RPCN","dates":{"release":"2020-01-01T00:00:00Z","publication":"2020 May","modification":"2025-04-29T10:56:57.06Z","creation":"2020-05-24T07:10:08Z"},"accession":"S-EPMC7222444","cross_references":{"pubmed":["32404183"],"doi":["10.1186/s12951-020-00626-1"]}}